3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Urinary Bladder Neoplasms
2
Prostatic Neoplasms
2
Prostatic Intraepithelial Neoplasia
1
Neoplasms
1
Eye Diseases
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Cardiovascular Diseases
1
Interventions
enzalutamide
1
beta Carotene
1
Vitamin E
1
Prednisone
1
Gonadotropin-Releasing Hormone
1
Geritol
1
Behavior Therapy
1
Ascorbic Acid
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cognitive Dysfunction
×
Geritol
×
Genitourinary
×
Clear all
NCT00270647
2018-02-28
PHS II
Brigham and Women's Hospital
Phase NA
Completed
14,641 enrolled